SCHEMBL13487209

SCHEMBL13487209

CC1(C)c2ccccc2-c2c(-c3c4ccccc4c(-c4ccc5c(c4)-c4ccccc4[Si]5(C)C)c4ccc(-c5cccc6ccccc56)cc34)cccc21

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RORA P35398 1/20 0.32
RORC P51449 1/20 0.32
MCL1 Q07820 1/20 0.30
ACMSD Q8TDX5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487642 0.92 RORA (0.33) RORARORCMCL1ACMSD
SCHEMBL13487319 0.91 RORA (0.32) RORARORC
SCHEMBL13488005 0.91 RORA (0.33) RORARORCMCL1ACMSD
SCHEMBL13487139 0.90 RORA (0.33) RORARORC
SCHEMBL13487396 0.89 RORA (0.33) RORARORC
SCHEMBL13487211 0.89
SCHEMBL13487085 0.88 RORA (0.33) RORARORC
SCHEMBL13487223 0.87 KDM4E (0.32)
SCHEMBL12796289 0.86 RORA (0.30) RORARORCMCL1ACMSD
SCHEMBL13487199 0.83 MEN1 (0.31) MCL1ACMSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 RORA 2000/4885RORC 2010/4885MCL1 2343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.